Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroacanthocytosis.

Adrian Danek1, Ruth H Walker

  • 1Neurologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Germany. danek@lmu.de

Current Opinion in Neurology
|July 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Accuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases.

Journal of neurology·2026
Same author

Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia.

NeuroImage. Clinical·2026
Same author

Dancing in Chaos: The Need for a Classification System for Chorea.

Movement disorders clinical practice·2026
Same author

Proceedings of the 12<sup>th</sup> International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026
Same author

A novel hierarchical framework elucidating regional differences in α-synuclein and tau co-pathology in military veterans with parkinsonism.

Journal of neuropathology and experimental neurology·2025
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Neuroacanthocytosis syndromes are a group of heterogeneous disorders. Advances in genetic testing improve diagnostic accuracy, aiding recognition and management of these rare neurodegenerative conditions.

Area of Science:

  • Neurology
  • Genetics
  • Molecular Medicine

Background:

  • Neuroacanthocytosis encompasses a heterogeneous group of disorders, leading to diagnostic challenges.
  • Distinguishing neuroacanthocytosis from other conditions affecting gait, like lipoprotein deficiencies, is crucial.
  • Neuropsychiatric and movement disorders are characteristic of true neuroacanthocytosis syndromes.

Purpose of the Study:

  • To review the current understanding of neuroacanthocytosis syndromes.
  • To facilitate clinical recognition, accurate diagnosis, and appropriate patient management.
  • To highlight the importance of differentiating various neuroacanthocytosis subtypes.

Main Methods:

  • Review of recent advances in molecular medicine and genetic testing.

Related Experiment Videos

  • Analysis of phenotypic variations across different neuroacanthocytosis conditions.
  • Discussion of improved methods for acanthocytosis determination.

    • Main Results:

    • Molecular advances allow precise differentiation between disorders like chorea-acanthocytosis and McLeod syndrome.
    • Acanthocytosis is also observed in pantothenate kinase-associated neurodegeneration (PKAN) and Huntington's disease-like 2 (HDL2).
    • Improved acanthocytosis detection methods are available.

    Conclusions:

    • Genetic testing enhances diagnostic accuracy for neuroacanthocytosis syndromes.
    • Improved recognition and understanding of disease processes are facilitated by genetic insights.
    • Genetic counseling is vital due to the absence of a cure; treatments remain symptomatic.